The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Optimizing frontline therapy for diffuse large B cell lymphoma (DLBCL) in older adults: A glofitamab-based, response-adapted, window-style study (GLORY).
 
Pallawi Torka
Consulting or Advisory Role - Abbvie; Bristol Myers Squibb Foundation; Genentech; Genmab; Lilly; Pfizer; Seagen
 
Koshy Alexander
No Relationships to Disclose
 
Kelly McConnell
No Relationships to Disclose
 
Venkatraman Seshan
No Relationships to Disclose
 
Joanna Tortora
No Relationships to Disclose
 
Holly Levenstein
No Relationships to Disclose
 
Olivia Kelly
No Relationships to Disclose
 
Helen Jacob
No Relationships to Disclose
 
Monifa Douglas
No Relationships to Disclose
 
Walter Ramos Amador
No Relationships to Disclose
 
Justina Kiernan
No Relationships to Disclose
 
Zachary Epstein-Peterson
Consulting or Advisory Role - Genmab
 
Lorenzo Falchi
Consulting or Advisory Role - Abbvie; ADC Therapeutics; AstraZeneca; EvolveImmune Therapeutics; Genmab; Ipsen; Roche/Genentech; Seagen
Research Funding - Abbvie; BeiGene; Genentech; Genmab; Innate Pharma; Roche
Travel, Accommodations, Expenses - Abbvie; Genmab
 
Andrew Zelenetz
Honoraria - Curio Science; NCCN; OncLive/MJH Life Sciences
Consulting or Advisory Role - AstraZeneca; BeiGene; Celgene; Dava Oncology; Genentech/Roche; Ipsen; Juno/Celgene/Bristol-Myers Squibb; Kite, a Gilead company; MEI Pharma; Ono Pharmaceutical; Sandoz
Research Funding - Abbvie (Inst); Arvinas (Inst); BeiGene; Genentech/Roche; MEI Pharma; Pharmacyclics/Janssen (Inst)
Travel, Accommodations, Expenses - BeiGene; Kite, a Gilead company; NCCN
 
Gilles Salles
Stock and Other Ownership Interests - Owkin
Honoraria - Abbvie
Consulting or Advisory Role - Abbvie; BeiGene; BMS; Epizyme; Genmab; Incyte; Ipsen; Janssen; Kite/Gilead; Loxo/Lilly; Merck; MODEX; Novartis; Nurix; Orna Therapeutics; Pfizer; Roche/Genentech; Treeline Biosciences
Research Funding - Abbvie (Inst); Genentech (Inst); Genmab (Inst); Ipsen (Inst); Janssen (Inst); nurix (Inst)
 
Paul Hamlin
Employment - Agios (I)
Stock and Other Ownership Interests - Agios (I)
Consulting or Advisory Role - ADC Therapeutics; Beigene; Pfizer
Research Funding - GlaxoSmithKline (Inst); Incyte (Inst); Janssen (Inst); molecular templates (Inst); Portola Pharmaceuticals (Inst); Seagen (Inst); Spectrum Pharmaceuticals (Inst)